Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
AOL3d
Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro ... companies that make cheaper copies of tirzepatide will face new restrictions on marketing those medications.
BioSpace12d
Novo CEO, Sanders to Face Off Over US Prices for Ozempic and Wegovy
In a high-profile showdown Tuesday with Sen. Bernie Sanders’ Senate health committee, Novo Nordisk CEO Lars Fruergaard ...
Benefits Pro8d
Employer plans face GLP-1 anti-obesity drug rebate threats
About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...
GLP-1 weight-loss meds might interfere with endoscopy, colonoscopy
Research shows patients taking weight-loss drugs like Ozempic and Wegovy are more likely to have food left in the stomach or ...
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...
Obesity doctor calls for end to stigma with federal act and better treatment options | Opinion
Obesity is not a choice, it’s a chronic disease, says expert. The Treat and Reduce Obesity Act could have potential impact on ...